Short Daily Versus Conventional Hemodialysis for COVID-19 Patients
NCT ID: NCT05212675
Last Updated: 2022-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
47 participants
INTERVENTIONAL
2021-03-01
2021-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Also the potential variants according with worse outcomes remain to be fully elucidated.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
COVID-19 Infection in Hemodialysis Patients
NCT05069532
Effects of Different Dialysis Strategies on Inflammation in COVID-19 Maintenance Hemodialysis Patients
NCT04685447
Less Frequency Hemodialysis and COVID-19
NCT04374058
Reducing Dialysate Sodium Effect on Blood Pressure Variability in Hemodialysis Patients
NCT05169125
COVADIAL - Immunogenicity of COVID-19 Vaccine in Hemodialysis Patients
NCT04728828
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
short daily dialysis
7 days 2hours dialysis
Short daily dialysis
7 days 2hours dialysis
conventional dialysis
3 times weekly 4hours dialysis
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Short daily dialysis
7 days 2hours dialysis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shahid Beheshti University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
nooshin dalili
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nooshin Dalili, MD
Role: PRINCIPAL_INVESTIGATOR
SBMU
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nooshin Dalili
Tehran, , Iran
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SBMU-1400-10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.